Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI)

NCT: NCT03529799 · TERMINATED

NCT IDNCT03529799
StatusTERMINATED
Start Date2018-04-20
Completion2019-09-25
SponsorUniversity of Miami (OTHER)
First posted
Last updated

Brief Summary

This study aims to determine the validity and safety of disparity driven vergence using a portable goggle system (I-PAS) using a pseudorandom ternary sequence of frequencies for testing.

Frequently Asked Questions

What is Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI)?

Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI) is a clinical trial registered under NCT03529799. Current status: TERMINATED.

What is the status of NCT03529799?

The current status of NCT03529799 (Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI)) is: TERMINATED.

When did Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI) start?

Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI) started on 2018-04-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑